Cargando…

Editorial: Cannabidiol treatment in neurotherapeutic interventions, volume II

Detalles Bibliográficos
Autores principales:	Gonzalez-Cuevas, Gustavo, Navarrete, Francisco, Garcia-Gutierrez, Maria S., de Guglielmo, Giordano, Manzanares, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996324/ https://www.ncbi.nlm.nih.gov/pubmed/36909164 http://dx.doi.org/10.3389/fphar.2023.1163991

Ejemplares similares

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

Cannabidiol and Sertraline Regulate Behavioral and Brain Gene Expression Alterations in an Animal Model of PTSD
por: Gasparyan, Ani, et al.
Publicado: (2021)

Unveiling behavioral and molecular neuroadaptations related to the antidepressant action of cannabidiol in the unpredictable chronic mild stress model
por: García-Gutiérrez, María Salud, et al.
Publicado: (2023)

Mechanisms of manganese-induced neurotoxicity and the pursuit of neurotherapeutic strategies
por: Pajarillo, Edward, et al.
Publicado: (2022)

Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects
por: Rajput, Amarjitsing, et al.
Publicado: (2022)

Editorial: Glaucoma: In Search of Better Neurotherapeutics
por: Russo, Rossella, et al.
Publicado: (2018)

Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
por: García-Gutiérrez, María S., et al.
Publicado: (2020)

Editorial: Purinergic pharmacology, Volume II
por: Ciruela, Francisco, et al.
Publicado: (2023)

Editorial: Chronic inflammation and pharmacological interventions in cardiovascular diseases, volume II
por: Yan, Aiwei, et al.
Publicado: (2023)

Editorial: Reducing the harm of medication–recent trends in pharmacovigilance (volume II)
por: Ramírez, Elena, et al.
Publicado: (2023)

Editorial: The Search for Biomarkers in Psychiatry
por: Garcia-Gutierrez, Maria S., et al.
Publicado: (2021)

Editorial: Eicosanoids in cancer, Volume II
por: Patrignani, Paola, et al.
Publicado: (2023)

Exosome: The “Off-the-Shelf” Cellular Nanocomponent as a Potential Pathogenic Agent, a Disease Biomarker, and Neurotherapeutics
por: Ghosh, Satyajit, et al.
Publicado: (2022)

Editorial: Neuroprotection and disease modification in Parkinson’s disease: Volume II
por: Otero-Losada, Matilde, et al.
Publicado: (2023)

Mitochondrial Photobiomodulation as a Neurotherapeutic Strategy for Epilepsy
por: Cardoso, Fabrízio dos Santos, et al.
Publicado: (2022)

Editorial: The Potential of Machine-learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology: Volume II
por: Garcia-Agundez, Augusto, et al.
Publicado: (2023)

Editorial: Venoms, animal and microbial toxins, volume II
por: Cao, Zhijian, et al.
Publicado: (2022)

Editorial: Current Aspects in Chemopreventive Strategies, Volume II
por: Tuli, Hardeep Singh, et al.
Publicado: (2022)

Editorial: Autophagy in inflammation related diseases, volume II
por: Shao, Bo-Zong, et al.
Publicado: (2023)

Editorial: Antimalarial chemotherapy in the XXIst century, volume II
por: Gomes, Paula, et al.
Publicado: (2023)

Editorial: Novel therapeutic approaches for the treatment of ocular disease, Volume II
por: Thermos, Kyriaki, et al.
Publicado: (2022)

Editorial: Novel approaches to the treatment of multidrug-resistant bacteria, Volume II
por: Pusparajah, Priyia, et al.
Publicado: (2022)

Role of multidrug transporters in neurotherapeutics
por: Jose, Manna, et al.
Publicado: (2009)

Neurotherapeutics for ADHD: Do they work?
por: Rubia, Katya
Publicado: (2022)

Editorial: Imaging technology in oncology pharmacological research, volume II
por: Zeng, Qi, et al.
Publicado: (2022)

Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease, Volume II
por: Bucolo, Claudio, et al.
Publicado: (2022)

Editorial: Hydrogen sulfide: Physiology, Pharmacology and Toxicology, Volume II
por: Bian, Jin-Song
Publicado: (2022)

Editorial: Pharmacological approaches targeting neutrophilic inflammation: Volume II
por: Sokolov, Alexey V., et al.
Publicado: (2022)

Editorial: Resolution of inflammation: Mechanisms, mediators and biomarkers: Volume II
por: Patrignani, Paola, et al.
Publicado: (2022)

Editorial: Neurodegeneration, cell signaling and neuroreparative strategies, Volume II
por: Vaz, Ana Rita, et al.
Publicado: (2023)

Editorial: Microbiome in IBD: From Composition to Therapy, Volume II
por: Liu, Ning-Ning, et al.
Publicado: (2023)

Editorial: Experimental models of epilepsy and related comorbidities, Volume II
por: Shaikh, Mohd Farooq, et al.
Publicado: (2023)

Editorial: Medication safety in COVID-19 management, Volume II
por: Das, Saibal
Publicado: (2023)

Editorial: Receptor biology and cell signaling in diabetes: volume II
por: Srivastava, Swayam Prakash, et al.
Publicado: (2023)

Editorial: The roles of ion-induced cell death in cancer treatment: volume II
por: Zhang, Kui, et al.
Publicado: (2023)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020)

Editorial: Modulating lymphatic vascular growth in disease: current and potential pharmacological approaches for prevention and treatment, Volume II
por: Trevaskis, Natalie L., et al.
Publicado: (2023)

Editorial: Natural products as an emerging therapeutic alternative for the treatment of anxiety and depression, Volume II
por: Khan, Ajmal, et al.
Publicado: (2022)

Editorial: Application of plant secondary metabolites to pain neuromodulation, volume II
por: Singla, Rajeev K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5joaf3n081o5kpcnq37mo0b67p